NYX-458 improves cognitive performance in a primate Parkinson's disease model

Barth, AL; Schneider, JS; Johnston, TH; Hill, MP; Brotchie, JM; Moskal, JR; Cearley, CN

MOVEMENT DISORDERS, 2020; 35 (4): 640

Abstract

BACKGROUND NYX-458 is a N-methyl-d-aspartate receptor (NMDAR) modulator that enhances synaptic plasticity. Dopaminergic cell loss in Parkinson's disea......

Full Text Link